Changeflow GovPing Pharma & Drug Safety Biallelic Knockout CISH Gene, RNA Compositions
Routine Notice Added Final

Biallelic Knockout CISH Gene, RNA Compositions

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

USPTO published patent application US20260097121A1 by inventor Rafi Emmanuel covering RNA compositions with guide sequences targeting the CISH gene for biallelic knockout. The application includes sequences defined by SEQ ID NOs 1-6838 and methods for their use. Filing date was September 18, 2023, under application number 19113098.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO published patent application US20260097121A1 covering compositions comprising RNA molecules with guide sequences of 17-50 contiguous nucleotides targeting CISH gene sequences defined by SEQ ID NOs 1-6838, along with associated methods and uses.

Affected parties including biotech researchers, gene therapy developers, and pharmaceutical companies should monitor this application for potential licensing opportunities or freedom-to-operate considerations in CISH-related gene editing technologies.

What to do next

  1. Monitor for patent grant status

Archived snapshot

Apr 14, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Biallelic Knockout of CISH

Application US20260097121A1 Kind: A1 Apr 09, 2026

Inventors

Rafi EMMANUEL

Abstract

Compositions comprising an RNA molecule comprising a guide sequence portion having 17-50 contiguous nucleotides containing nucleotides in the sequence set forth in any one of SEQ ID NOs: 1-6838 and methods and uses thereof.

CPC Classifications

A61K 40/34 A61K 40/11 C12N 9/226 C12N 15/11 C12N 15/907 C12N 2310/20

Filing Date

2023-09-18

Application No.

19113098

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260097121A1

Who this affects

Applies to
Drug manufacturers Healthcare providers Clinical investigators
Industry sector
3254.1 Biotechnology 3254 Pharmaceutical Manufacturing
Activity scope
Patent filing Gene therapy research RNA composition development
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!